Development and performance of prototype serologic and molecular tests for hepatitis delta infection
Abstract Worldwide, an estimated 5% of hepatitis B virus (HBV) infected people are coinfected with hepatitis delta virus (HDV). HDV infection leads to increased mortality over HBV mono-infection, yet HDV diagnostics are not widely available. Prototype molecular (RNA) and serologic (IgG) assays were...
Enregistré dans:
Auteurs principaux: | Kelly E. Coller, Emily K. Butler, Ka-Cheung Luk, Mary A. Rodgers, Michael Cassidy, Jeffrey Gersch, Anne L. McNamara, Mary C. Kuhns, George J. Dawson, Lazare Kaptue, Birgit Bremer, Heiner Wedemeyer, Gavin A. Cloherty |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cecdf5f3f90443218de37d948b89f5d9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers
par: Mary C. Kuhns, et autres
Publié: (2021) -
Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021
par: Asish Kumar Ghosh, et autres
Publié: (2021) -
Integration of sensors for dam water quality analysis – a prototype
par: Lina Rose, et autres
Publié: (2021) -
Virtual and physical prototyping
Publié: (2006) -
Rapid prototyping journal
Publié: (1995)